Biomedical Science Letters (대한의생명과학회지)

The Korean Society for Biomedical Laboratory Sciences (대한의생명과학회)
권호 표지
DOI QR코드

DOI QR Code

A Comparison of Genospecies of Clinical Isolates in the Acinetobacter spp. Complex Obtained from Hospitalized Patients in Busan, Korea

  • Park, Gyu-Nam (Department of Clinical Laboratory Science, College of Health Sciences, Catholic University of Pusan) ;
  • Kang, Hye-Sook (Department of Laboratory Medicine, Maryknoll Medical Center) ;
  • Kim, Hye-Ran (Department of Clinical Laboratory Science, College of Health and Therapy, Daegu Haany University) ;
  • Jung, Bo-Kyung (Department of Clinical Laboratory Science, College of Health Sciences, Catholic University of Pusan) ;
  • Kim, Do-Hee (Department of Laboratory Medicine, Busan Veterans Hospital) ;
  • Chang, Kyung-Soo (Department of Clinical Laboratory Science, College of Health Sciences, Catholic University of Pusan)
  • Received : 2018.12.18
  • Accepted : 2019.01.14
  • Published : 2019.03.31
Download PDF
⟨ Previous Next ⟩

Abstract

Of the Acinetobacter spp., A. baumannii (genospecies 2) is the most clinically significant in terms of hospital-acquired infections worldwide. It is difficult to perform Acinetobacter-related taxonomy using phenotypic characteristics and routine laboratory methods owing to clusters of closely related species. The ability to accurately identify Acinetobacter spp. is clinically important because antimicrobial susceptibility and clinical relevance differs significantly among the different genospecies. Based on the medical importance of pathogenic Acinetobacter spp., the distribution and characterization of Acinetobacter spp. isolates from 123 clinical samples was determined in the current study using four typically applied bacterial identification methods; partial rpoB gene sequencing, amplified rRNA gene restriction analysis (ARDRA) of the intergenic transcribed spacer (ITS) region of the 16~23S rRNA, the $VITEK^{(R)}$ 2 system (an automated microbial identification system) and matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF MS). A. baumannii isolates (74.8%, 92/123) were the most common species, A. nosocomialis (10.6%, 13/123) and A. pittii isolates (7.5%, 9/123) were second and third most common strains of the A. calcoaceticus-A. baumannii (ACB) complex, respectively. A. soli (5.0%, 6/123) was the most common species of the non-ACB complex. RpoB gene sequencing and ARDRA of the ITS region were demonstrated to lead to more accurate species identification than the other methods of analysis used in this study. These results suggest that the use of rpoB genotyping and ARDRA of the ITS region is useful for the species-level identification of Acinetobacter isolates.

Keywords

References

  1. Almasaudi SB. Acinetobacter spp. as nosocomial pathogens: Epidemiology and resistance features. Saudi J Biol Sci. 2018. 25: 586-596. https://doi.org/10.1016/j.sjbs.2016.02.009
  2. Antunes LC, Visca P, Towner KJ. Acinetobacter baumannii: evolution of a global pathogen. Pathog Dis. 2014. 71: 292-301. https://doi.org/10.1111/2049-632X.12125
  3. Cisneros JM, Rodriguez-Bano J. Nosocomial bacteremia due to Acinetobacter baumannii: epidemiology, clinical features and treatment. Clin Microbiol Infect. 2002. 8: 687-693. https://doi.org/10.1046/j.1469-0691.2002.00487.x
  4. Croxatto A, Prod'hom G, Greub G. Applications of MALDI-TOF mass spectrometry in clinical diagnostic microbiology. FEMS Microbiol Rev. 2012. 36: 380-407. https://doi.org/10.1111/j.1574-6976.2011.00298.x
  5. Dingle TC, Butler-Wu SM. Maldi-tof mass spectrometry for microorganism identification. Clin Lab Med. 2013. 33: 589-609. https://doi.org/10.1016/j.cll.2013.03.001
  6. Endo S, Yano H, Kanamori H, Inomata S, Aoyagi T, Hatta M, Gu Y, Tokuda K, Kitagawa M, Kaku M. High frequency of Acinetobacter soli among Acinetobacter isolates causing bacteremia at a tertiary hospital in Japan. J Clini Microbiol. 2014. 52: 911-915. https://doi.org/10.1128/JCM.03009-13
  7. Jeong S, Hong JS, Kim JO, Kim KH, Lee W, Bae IK, Lee K, Jeong SH. Identification of Acinetobacter Species Using Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry. Ann Lab Med. 2016. 36: 325-334. https://doi.org/10.3343/alm.2016.36.4.325
  8. Khosravi AD, Sadeghi P, Shahraki AH, Heidarieh P, Sheikhi N. Molecular methods for identification of Acinetobacter species by partial sequencing of the rpoB and 16SrRNA genes. J Clin Diagn Res. 2015. 9: DC09-13.
  9. Koeleman JG, Stoof J, Biesmans DJ, Savelkoul PH, Vandenbroucke-Grauls CM. Comparison of amplified ribosomal DNA restriction analysis, random amplified polymorphic DNA analysis, and amplified fragment length polymorphism fingerprinting for identification of Acinetobacter genomic species and typing of Acinetobacter baumannii. J Clin Microbiol. 1998. 36: 2522-2529. https://doi.org/10.1128/JCM.36.9.2522-2529.1998
  10. La Scola B, Gundi VA, Khamis A, Raoult D. Sequencing of the rpoB gene and flanking spacers for molecular identification of Acinetobacter species. J Clin Microbiol. 2006. 44: 827-832. https://doi.org/10.1128/JCM.44.3.827-832.2006
  11. Lee MJ, Jang SJ, Li XM, Park G, Kook JK, Kim MJ, Chang YH, Shin JH, Kim SH, Kim DM, Kang SH, Moon DS. Comparison of rpoB gene sequencing, 16S rRNA gene sequencing, gyrB multiplex PCR, and the VITEK2 system for identification of Acinetobacter clinical isolates. Diagn Microbiol Infect Dis. 2014. 78: 29-34. https://doi.org/10.1016/j.diagmicrobio.2013.07.013
  12. Lee K, Yong D, Jeong SH, Chong Y. Multidrug-resistant Acinetobacter spp.: increasingly problematic nosocomial pathogens. Yonsei Med J. 2011. 52: 879-891. https://doi.org/10.3349/ymj.2011.52.6.879
  13. Maeda Y, Dobashi H, Sugiyama Y, Saeki T, Lim TK, Harada M, Matsunaga T, Yoshino T, Tanaka T. Colony fingerprint for discrimination of microbial species on lensless imaging of microcolonies. PLos One. 2017. 12: e0174723. https://doi.org/10.1371/journal.pone.0174723
  14. Tien N, You BJ, Chang HL, Lin HS, Lee CY, Chung TC, Lu JJ, Chang CC. Comparison of genospecies and antimicrobial resistance profiles of isolates in the Acinetobacter calcoaceticus-Acinetobacter baumannii complex from various clinical specimens. Antimicrob Agents Chemother. 2012. 56: 6267-6271. https://doi.org/10.1128/AAC.01304-12
  15. Vaneechoutte M, Dijkshoorn L, Tjernberg I, Elaichouni A, de Vos P, Claeys G, Verschraegen G. Identification of Acinetobacter genomic species by amplified ribosomal DNA restriction analysis. J Clin Microbiol. 1995. 33: 11-15. https://doi.org/10.1128/JCM.33.1.11-15.1995
  16. Visca P, Seifert H, Towner KJ. Acinetobacter infection-an emerging threat to human health. IUBMB Life. 2011. 63: 1048-1054. https://doi.org/10.1002/iub.534
  17. Wang J, Ruan Z, Feng Y, Fu Y, Jiang Y, Wang H, Yu Y. Species distribution of clinical Acinetobacter isolates revealed by different identification techniques. PLoS One. 2014. 9: e104882. https://doi.org/10.1371/journal.pone.0104882